The potential of human papillomavirus vaccines.
Steinbrook
Robert
R
Laboratory of Cellular Oncology at the National Cancer Institute, USA.
D000293:Adolescent; D000328:Adult; D001005:Anus Neoplasms / Q000517:prevention & control; D002648:Child; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D009856:Oncogene Proteins, Viral; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D014481:United States; D014565:Urogenital Neoplasms / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
D009856:Oncogene Proteins, Viral; D053918:Papillomavirus Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; C100344:human papillomavirus vaccine, TA